L-NMMA (a nitric oxide synthase inhibitor) is effective in the treatment of cardiogenic shock.
Cotter G, Kaluski E, Blatt A, Milovanov O, Moshkovitz Y, Zaidenstein R, Salah A, Alon D, Michovitz Y, Metzger M, Vered Z, Golik A.
Cotter G, et al. Among authors: blatt a.
Circulation. 2000 Mar 28;101(12):1358-61. doi: 10.1161/01.cir.101.12.1358.
Circulation. 2000.
PMID: 10736276
Clinical Trial.